Rockville's Supernus Pharmaceuticals announces record quarter and full-year financial results

Despite a December stock drop, Rockville's Supernus Pharmaceuticals found 2018 overall to be the best year in the company's history. Supernus announced Tuesday that it had its best full-year financial results ever, and 2018 also saw the firm's most successful single quarter results in history, as well.

For the year of 2018, Supernus enjoyed $408.9 million in total revenue, and full-year operating earnings of $144.4 million. Their record 4th quarter reported $115.9 million in total revenue, and operating earnings of $39.9 million. Last month, the company capped off the hot streak with their launch of Oxtellar XR, a partial seizure therapy product.

Biotech continues to be the rare exception in an overall moribund Montgomery County economy. Firms like Supernus and Silver Spring's United Therapeutics - which is completing an ambitious Unisphere campus expansion - have been the only bright spots as Northern Virginia continues to deliver a bruising beatdown in the competition for major corporate headquarters, of which Montgomery County has attracted none in two decades. Until voters force a change in the County's leadership direction on economic development, all we can do is cross our fingers and hope one of these smaller firms can make the leap to the Fortune 500.